Structural refinement of protein A mimetic peptide

Area of Science:

• Biotechnology
• Affinity Chromatography
• Protein Engineering

Background:

• Developing high-capacity affinity ligands is crucial for efficient downstream processing of therapeutic antibodies.
• Existing D-PAM matrices show potential but require optimization for enhanced binding capacity and selectivity.
• Computational modeling provides insights into ligand-protein interactions for rational design.

Purpose of the Study:

• To design and synthesize a novel dendrimeric peptide ligand, D-PAM-Φ, for enhanced human IgG capture.
• To evaluate the binding capacity and selectivity of the D-PAM-Φ affinity sorbent.
• To assess the efficacy of D-PAM-Φ in purifying recombinant humanized IgG1 from cell culture supernatants.

Main Methods:

• Design of D-PAM-Φ based on hydrophobic group introduction and computational modeling of D-PAM-Fc complex.
• Immobilization of D-PAM-Φ onto an activated solid support.
• Evaluation of binding capacity using polyclonal human IgG and purification of recombinant humanized IgG1 via affinity chromatography.

Main Results:

• D-PAM-Φ demonstrated a binding capacity of approximately 10 mg/ml, a nearly 10-fold increase compared to parent D-PAM matrices.
• Specificity of binding was maintained, ensuring selective capture of human IgG.
• Purification of humanized IgG1 from clarified cell culture supernatant yielded a product with >90% purity.

Conclusions:

• The novel D-PAM-Φ ligand offers a significant improvement in IgG binding capacity for affinity chromatography.
• Computational approaches are valuable for designing effective affinity ligands for antibody purification.
• D-PAM-Φ shows promise for the downstream processing of therapeutic human and humanized antibodies.